Boxer Capital Management, LLC Quant / Systematic

CIK: 0002018299 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $456,876 (100.0% shares, 0.0% debt)

Holdings (45)

New Positions (15)

Increased Positions (14)

KOD KODIAK SCIENCES INC 7.0%
Value ($000) $31,763 (+158.7%) Shares 1,136,000 (+51.5%) Est. Cost $10.75 Unrealized +90.6%
CELC CELCUITY INC 4.9%
Value ($000) $22,442 (+404.8%) Shares 225,000 (+150.0%) Est. Cost $65.33 Unrealized +25.8%
TNGX TANGO THERAPEUTICS INC 21.1%
Value ($000) $96,363 (+17.4%) Shares 10,876,219 (+11.3%) Est. Cost $5.05 Unrealized +70.7%
KYMR KYMERA THERAPEUTICS INC 5.6%
Value ($000) $25,607 (+41.8%) Shares 329,100 (+3.1%) Est. Cost $43.27 Unrealized +56.1%
PTGX PROTAGONIST THERAPEUTICS INC 3.2%
Value ($000) $14,848 (+103.2%) Shares 170,000 (+54.5%) Est. Cost $62.54 Unrealized +30.9%
CIDARA THERAPEUTICS INC 2.6%
Value ($000) $11,707 (+154.7%) Shares 53,000 (+10.4%) Est. Cost $64.95 Unrealized
ABVX ABIVAX SA 3.7%
Value ($000) $16,857 (+65.5%) Shares 125,000 (+4.2%) Est. Cost $86.90 Unrealized
MIND MEDICINE MINDMED INC 1.8%
Value ($000) $8,014 (+315.7%) Shares 598,500 (+266.1%) Est. Cost $12.95 Unrealized
AVTX AVALO THERAPEUTICS INC 1.1%
Value ($000) $4,994 (+214.3%) Shares 275,000 (+120.0%) Est. Cost $13.12 Unrealized +28.7%
APGE APOGEE THERAPEUTICS INC 1.2%
Value ($000) $5,284 (+166.0%) Shares 70,000 (+40.0%) Est. Cost $45.27 Unrealized +39.1%
PGEN PRECIGEN INC 1.3%
Value ($000) $5,748 (+105.5%) Shares 1,375,000 (+61.8%) Est. Cost $3.22 Unrealized +20.1%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.8%
Value ($000) $3,625 (+102.2%) Shares 275,000 (+10.0%) Est. Cost $48.45 Unrealized -75.7%
PEPG PEPGEN INC 0.5%
Value ($000) $2,434 (+110.7%) Shares 373,892 (+49.6%) Est. Cost $2.80 Unrealized +85.5%
INO INOVIO PHARMACEUTICALS INC 0.9%
Value ($000) $4,211 (-21.8%) Shares 2,420,122 (+5.2%) Est. Cost $1.93 Unrealized +14.2%

Decreased Positions (8)